RT Journal Article
SR Electronic
T1 Glaucoma Detection and Feature Visualization from OCT Images Using Deep Learning
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.06.23286879
DO 10.1101/2023.03.06.23286879
A1 Akter, Nahida
A1 Perry, Stuart
A1 Fletcher, John
A1 Simunovic, Matthew P.
A1 Stapleton, Fiona
A1 Roy, Maitreyee
YR 2023
UL http://medrxiv.org/content/early/2023/03/09/2023.03.06.23286879.abstract
AB Purpose In this paper, we aimed to clinically interpret Temporal-Superior-Nasal-Inferior-Temporal (TSNIT) retinal optical coherence tomography (OCT) images in a convolutional neural network (CNN) model to differentiate between normal and glaucomatous optic neuropathy.Methods Three modified pre-trained deep learning (DL) models: SqueezeNet, ResNet18, and VGG16, were fine-tuned for transfer learning to visualize CNN features and detect glaucoma using 780 segmented and 780 raw TSNIT OCT B-scans of 370 glaucomatous and 410 normal images. The performance of the DL models was further investigated with Grad-CAM activation function to visualize which regions of the images are considered for the prediction of the two classes.Results For glaucoma detection, VGG16 performed better than SqueezeNet and ResNet18 models, with the highest AUC (0.988) on validation data and accuracy of 93% for test data. Moreover, identical classification results were obtained from raw and segmented images. For feature localization, three models accurately identify the distinct retinal regions of the TSNIT images for glaucoma and normal eyes.Conclusion This evidence-based result demonstrates the remarkable effectiveness of using raw TSNIT OCT B-scan for automated glaucoma detection using DL techniques which mitigates the black box problem of artificial intelligence (AI) and increases the transparency and reliability of the DL model for clinical interpretation. Moreover, the results imply that the raw TSNIT OCT scan can be used to detect glaucoma without any prior segmentation or pre-processing, which may be an attractive feature in large-scale screening applications.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study adhered to all the tenets of the Declaration of Helsinki and was approved by the UNSW Sydney ethics committeeI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors